SCHEMBL321183

SCHEMBL321183

C=C(Br)CN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL491178 0.70
SCHEMBL246402 0.67
SCHEMBL603294 0.67
SCHEMBL6014450 0.67
SCHEMBL1261724 0.67
SCHEMBL77926 0.67
SCHEMBL606699 0.65
SCHEMBL3791294 0.64
SCHEMBL12523285 0.64
SCHEMBL7637637 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110872295-B Method for synthesizing imidazo [1,2-a ] indole compound 浙江工业大学 2021-07-27 CN claimed
CN-110872295-A Method for synthesizing imidazo [1,2-a ] indole compound 浙江工业大学 2020-03-10 CN claimed
CN-110872257-A Method for synthesizing imidazole compound 浙江工业大学 2020-03-10 CN claimed
US-6100373-A Functionalized diene monomers and polymers containing functionalized dienes and methods for their preparation IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2000-08-08 US claimed
EP-0832059-A1 METHOD FOR THE PREPARATION OF AN N-(2-BROMOALKYL)-AMIDE DERIVATIVE DSM N.V. (NL) 1998-04-01 EP claimed
WO-1997000237-A1 PROCESS FOR THE PREPARATION OF AN N-(2-BROMOALKYL)-AMIDE DERIVATE_______________________________________________________________ DSM N.V. (NL) 1997-01-03 WO claimed
US-20250026721-A1 COMPOUNDS AND METHODS FOR MODULATING RAS-PI3K VIVIDION THERAPEUTICS, INC. 2025-01-23 US disclosed
US-12162871-B2 Inhibitors of VAP-1 ACUCELA INC. (US) 2024-12-10 US disclosed
US-20240067612-A1 PHARMACEUTICAL COMPOSITIONS COMPRISING WRN HELICASE INHIBITORS VIVIDION THERAPEUTICS, INC. 2024-02-29 US disclosed
US-20240067612-A1 PHARMACEUTICAL COMPOSITIONS COMPRISING WRN HELICASE INHIBITORS VIVIDION THERAPEUTICS, INC. 2024-02-29 US disclosed
WO-2024010782-A1 PHARMACEUTICAL COMPOSITIONS COMPRISING WRN HELICASE INHIBITORS VIVIDION THERAPEUTICS, INC. (US) 2024-01-11 WO disclosed
US-11787791-B2 Inhibitors of VAP-1 ACUCELA INC. (US) 2023-10-17 US disclosed
US-11787791-B2 Inhibitors of VAP-1 ACUCELA INC. (US) 2023-10-17 US disclosed
EP-0523904-A1 Process for preparing azetidin-2-one derivatives Takasago International Corporation (JP) 1993-01-20 EP disclosed
EP-0282492-A1 ANTIMICROBIAL N-ACYL-2-AZETIDINONES THE UPJOHN COMPANY (US) 1988-09-21 EP disclosed
EP-0282492-A1 ANTIMICROBIAL N-ACYL-2-AZETIDINONES THE UPJOHN COMPANY (US) 1988-09-21 EP disclosed
EP-0232017-A1 Antimicrobial N-acyl-2-azetidinones THE UPJOHN COMPANY (US) 1987-08-12 EP disclosed
EP-0232017-A1 Antimicrobial N-acyl-2-azetidinones THE UPJOHN COMPANY (US) 1987-08-12 EP disclosed
WO-1987004429-A1 ANTIMICROBIAL N-ACYL-2-AZETIDINONES THE UPJOHN COMPANY (US) 1987-07-30 WO disclosed
WO-1987004429-A1 ANTIMICROBIAL N-ACYL-2-AZETIDINONES THE UPJOHN COMPANY (US) 1987-07-30 WO disclosed